secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001558370-21-016698
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Richard Eisenstadt resigns effective Dec 30, 2021; successor search underway
--------------------------------------------------------------------------------

- Richard I. Eisenstadt resigns as CFO effective Dec 30, 2021 to pursue opportunity at another development-stage pharma.
- Resignation not due to any disagreements with Company's operations, policies, practices, or auditors.
- Company has initiated a search to identify and recruit a new CFO; CEO Josh Disbrow signing the filing.
- No interim CFO named; current CFO to depart at month-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837021016698/0001558370-21-016698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837021016698/aytu-20211208x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-016698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer